Read more
"Starting in 2005, people in the US and Europe were inundated with media coverage announcing the between cervical cancer and the sexually transmitted virus HPV. Within a year, product ads promoted a vaccine targeting cancer's viral cause and girls and women were enrolled as early consumers of this new cancer vaccine. The knowledge of HPV's links to other cancers, notably anal and oral, soon followed, which identified new at-risk populations and ignited a variety of gendered and sexual issues related to cancer prevention. Sexualizing Cancer is the first book dedicated to the emergence and proliferation of the HPV vaccine. It shows how the late twentieth century scientific breakthrough that identified the human papilloma virus as having a causative role in the onset of human cancer ignited sexual politics, struggles for inclusion, new risk identities, and, ultimately, a new regime of cancer prevention. Mamo reveals how gender and other equity arguments from within scientific, medical, and advocate communities shaped vaccine guidelines, clinical trial funding, research practices, and clinical programs, with consequences that reverberate today. This is a must-read history of medical expansion-from a "woman's disease" to a set of cancers that affect all genders-and of lingering sexualization, with specific gendered, racialized, and other contours along the way. Selling points: Reveals how cervical cancer became a highly visible cancer, while other HPV-related cancers were downplayed Makes clear how the places and people that could most benefit from a vaccine were the one's farthest from receiving its benefits Up-to-date account drawing on interviews with scientists and clinicians, observation at professional meetings, and analysis of scientific literature and media"--
About the author
Laura Mamo is professor in the Health Equity Institute at the San Francisco State University. She is the author of
Queering Reproduction: Achieving Pregnancy in the Age of Technoscience, coauthor of
Living Green: Communities that Sustain, and coeditor of
Biomedicalization Studies: Technoscience and Transformations of Health, Illness, and U.S. Biomedicine.
